Modern Drug Discovery Process of Synthetic Drug in Cancer: A Review

Read full text Summarise with VIRAT
Authors: Kavitha K*, Niranjana C M, Archamol. V. U, Numra. A. P, Fathima Liyana. K. K, Fousana Sherin, Fahid. A. K, Ali Ahammed H, Gowrishankar N L
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

For more than three decades, the generation of therapeutically significant small molecules has been greatly aided by computer-aided drug discovery and design techniques. These techniques can be broadly classified as structure-based or ligand-based techniques. In theory, high-throughput screening and structure-based approaches are similar in that both target and ligand structure information are relevant. Ligand docking, pharmacophore, and ligand design techniques are examples of structure-based methods. Cancers are a large family of diseases which involve abnormal cell growth with the potential to invade or spread to other parts of the body. They form a subset of neoplasms. A neoplasm or tumor is a group of cells that have undergone unregulated growth, and will often form a mass or lump, but may be distributed diffusely. CADD is typically used in drug discovery campaigns for three main reasonsto reduce large compound libraries into manageable sets of predicted active compounds that can be tested experimentally; to direct the optimisation of lead compounds, whether to boost their affinity or optimise drug metabolism and pharmacokinetics (DMPK) properties, including absorption, distribution, metabolism, excretion, and the potential for toxicity (ADMET) and to design novel compounds, Finally, optimisation of the target and therapeutic compounds' advantageous physiological features using computational approaches for toxicity prediction.

Fields of Study & Subjects

Computational Drug Discovery Methods Synthesis and Characterization of Heterocyclic Compounds Heterocyclic Compound Synthesis and Bioactivity

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
25 March 2026
Language
EN